Sean S Park

12PUBLICATIONS
119CO-AUTHORS
Radiation therapyPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Aug 08, 2026
Suppression of early pro-inflammatory senescent signature post-radiotherapy mitigates chronic bone damage.

|Apr 30, 2026
Early ctDNA Stratifies Survival in Locally Advanced and Oligometastatic Lung Cancer Treated with Radiotherapy.

|May 07, 2025
Outcomes of Radium-223 and Stereotactic Ablative Radiotherapy Versus Stereotactic Ablative Radiotherapy for Oligometastatic Prostate Cancers: The RAVENS Phase II Randomized Trial.

Jarey H Wang, Alexander D Sherry, Soha Bazyar

|Mar 14, 2025
Plasma exchange and radiation resensitize immunotherapy-refractory melanoma: a phase I trial.

Jacob J Orme, Henan Zhang, Prashanth Lingamaneni

|Jan 17, 2025
PSMA+ Extracellular Vesicles Are a Biomarker for SABR in Oligorecurrent Prostate Cancer: Analysis from the STOMP-like and ORIOLE Trial Cohorts.

Jack R Andrews, Yohan Kim, Edlira Horjeti

|Aug 23, 2024
Genomic and Epigenomic Analysis of Plasma Cell-Free DNA Identifies Stemness Features Associated with Worse Survival in Lethal Prostate Cancer.

Pradeep S Chauhan, Irfan Alahi, Savar Sinha

Pageof 2

Frequent Collaborators

6 joint publications

Jacob J Orme

5 joint publications

Aaron S Mansfield

5 joint publications

Haidong Dong

4 joint publications

Fabrice Lucien